A股重磅！又有两家公司筹划重大资产重组！

Group 1 - Xiangrikui is planning to acquire controlling stakes in Xi Pu Materials and 40% of Bei De Pharmaceutical through share issuance and/or cash payment, with the transaction expected to constitute a major asset restructuring [2][3] - The transaction is currently in the planning stage, and the valuations for Xi Pu Materials and Bei De Pharmaceutical have not been finalized yet [2] - The company has signed a letter of intent for the transaction and will disclose the transaction plan by September 22, 2023, or the stock will resume trading and terminate the restructuring plans [3] Group 2 - *ST Bosen intends to sell 35% of its stake in Shaanxi Bosen to Nantong Erfangji, which is expected to constitute a major asset restructuring [4] - This transaction does not involve share issuance and will not lead to a change in the controlling shareholder or actual controller [4] - The company reported a revenue of 51.95 million yuan and a net loss of 10.46 million yuan for the first half of 2025, with warnings of potential delisting if financial indicators trigger relevant conditions [4] Group 3 - As of September 7, over ten A-share listed companies, including *ST Bosen and Xiangrikui, have disclosed updates on merger and restructuring progress [5]